PARP1 and osteosarcoma: Therefore, in agreement with findings that PARP inhibition could be a promising therapeutic modality for the treatment of human cancers [42], the result of this study present the possibility that PARP inhibition could be an effective treatment of osteosarcomas by affecting the survival of cancer cells.